High levels of antibody in adults three years after vaccination with a reduced antigen content diphtheria-tetanus-acellular pertussis vaccine

PB McIntyre, FM Turnbull, AM Egan, MA Burgess… - Vaccine, 2004 - Elsevier
antigen content diphtheria and tetanus (Td) vaccines, the response to both tetanus and
diphtheria … geometric mean concentrations (GMCs) for tetanus were higher in the groups that …

Booster vaccination of adults with reduced-antigen-content diphtheria, tetanus and pertussis vaccine: immunogenicity 5 years post-vaccination

PB McIntyre, MA Burgess, A Egan, L Schuerman… - Vaccine, 2009 - Elsevier
… , Rixensart, Belgium) is a reduced-antigen-content vaccine containing diphtheria and
tetanus toxoids and three pertussis antigens (pertussis toxoid: PT, filamentous haemagglutinin: …

Decennial administration of a reduced antigen content diphtheria and tetanus toxoids and acellular pertussis vaccine in young adults

J Mertsola, O Van Der Meeren, Q He… - Clinical infectious …, 2010 - academic.oup.com
… Booster vaccination against tetanus and diphtheria at 10-year intervals is commonly
recommended. Reduced antigen content diphtheria and tetanus toxoids and acellular pertussis (…

… vaccination of adults with reduced antigen-content diphtheria-tetanus-acellular pertussis or dTpa-inactivated poliovirus vaccines compared to diphtheria-tetanus …

H Theeten, H Rümke, FJP Hoppener… - … medical research and …, 2007 - Taylor & Francis
… In adults, pertussis booster vaccination is provided using combined reduced-antigen
content diphtheria, tetanus and acellular pertussis (dTpa,) or dTpainactivated polio (dTpa-IPV) …

Immunogenicity and reactogenicity of a reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine in healthy Taiwanese children and adolescents

LM Huang, LY Chang, H Tang, HL Bock, CY Lu… - Journal of Adolescent …, 2005 - Elsevier
diphtheria and tetanus is currently maintained by booster vaccination at 5- to 10-year intervals.
A reduced-antigen-content diphtheria-tetanus (… Utilizing a reduced antigen dTpa vaccine …

Reduced-antigen-content-diphtheria-tetanus-acellular-pertussis and inactivated polio vaccine as a booster for adolescents 10 to 14 years of age

R Vergara, M Tregnaghi, J Ussher, S Navarro… - European journal of …, 2005 - Springer
… of acellular pertussis antigens with routinely used booster vaccines such as diphtheria, tetanus
and … of a combined reduced-antigen-content diphtheria-tetanus-acellular-pertussis and …

A decennial booster dose of reduced antigen content diphtheria, tetanus, acellular pertussis vaccine (Boostrix™) is immunogenic and well tolerated in adults

R Booy, O Van Der Meeren, SP Ng, F Celzo… - Vaccine, 2010 - Elsevier
Reduced-antigen-content diphtheriatetanus–acellular-… (antibodies ≥0.1IU/mL) for
diphtheria and tetanus, respectively. … /seropositive against all vaccine antigens. Robust GMC …

Physico-chemical and antigenic properties of tetanus and diphtheria toxoids and steps towards improved stability

P Johansen, HP Merkle, B Gander - Biochimica et Biophysica Acta (BBA) …, 1998 - Elsevier
… Here, we report on the physico-chemical, conformational and antigenic stability of tetanus
and diphtheria toxoids in solution as a function of temperature, and the presence of lactic and …

Immunogenicity of reduced antigen content tetanusdiphtheria–acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing …

F Zepp, P Habermehl, M Knuf, W Mannhardt-Laakman… - Vaccine, 2007 - Elsevier
… The tolerability of booster vaccination with a reduced-antigen-content tetanusdiphtheria–…
when these same individuals received their fifth diphtheriatetanus–acellular pertussis (DTaP) …

Repeated administration of a reduced-antigen-content diphtheria-tetanus-acellular pertussis and poliomyelitis vaccine (dTpa-IPV; Boostrix™ IPV)

M Knuf, V Vetter, F Celzo, G Ramakrishnan… - Human …, 2010 - Taylor & Francis
… , adult tetanus-diphtheria vaccine Reduced-antigen-content diphtheria tetanus and acellular
… could be reduced by replacing tetanus and diphtheria (Td) boosters with reduced-antigen-…